AWaRe antibiotic prescribing for common acute infections in low-middle income countries – a patient level analysis using IQVIA prescriber surveys from Pakistan, Egypt and Indonesia
Abstract
ABSTRACT Background There is limited large-scale and high-quality data on antibiotic prescribing in low- and middle- income countries (LMICs), particularly in the private sector. Here we use healthcare surveys to assess antibiotic prescribing levels and the factors influencing prescribing decisions for common infections in primary care and outpatient settings, predominantly within the private sector, in Pakistan, Egypt, and Indonesia. Methods We analysed surveys completed by prescribers in Pakistan, Egypt, and Indonesia, collected in primary care and outpatient settings, predominantly within the private sector, by IQVIA between 2017 and 2021, namely IQVIA’s proprietary Medical Data Index (Medical Index of Pakistan (MIP), Egypt Medical Data Index (EMDI) and Indonesia Medical Data Index (IMDI)). IQVIA market research information reflects estimates of real world activity and should be treated accordingly. We evaluated antibiotic prescribing categorized by WHO AWaRe and Essential Medicines List (EML) classifications for common infections. We used mixed-effects regression analyses to identify factors influencing prescribing decisions. Results Among the 384,975 infection-related health consultation records analysed, antibiotics were prescribed overall in 82.0% of consultations in Pakistan, 81.2% in Egypt, and 69.1% in Indonesia. Watch antibiotics accounted for 70.2% of all antibiotic prescriptions in Pakistan, 52.9% in Egypt, and 53.6% in Indonesia. Non-WHO EML antibiotics…
Read the paper
Related studies
- Impact of antibiotics on the human microbiome and consequences for host health
- Antibiotics in the clinical pipeline in October 2019
- The incidence of collagen-associated adverse events in pediatric population with the use of fluoroquinolones: a nationwide cohort study in Taiwan
- Research Communications of the 32nd ECVIM-CA Online Congress
- Singlet-Oxygen Therapy. Scientific And Methodological Materials
- Artificial Intelligence in Pharmacovigilance
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.